Yongchao Zhao

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Breast Cancer Cells

Dna Damage Response

Top Venues

Cell death and differentiation

Signal transduction and targeted therapy

Cell death discovery

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Shizhen Zhang, Qing Yu, Zhijian Li, Yongchao Zhao, Yi Sun
Protein neddylation and its role in health and diseases. Signal transduction and targeted therapy 9 (1) (2024)
Shizhen Zhang, Qing Yu, Zhijian Li, Yongchao Zhao, Yi Sun
Protein neddylation and its role in health and diseases. Signal transduction and targeted therapy 9 (1) (2024)
Shizhen Zhang, Qing Yu, Zhijian Li, Yongchao Zhao, Yi Sun
Protein neddylation and its role in health and diseases. Signal transduction and targeted therapy 9 (1) (2024)
Shizhen Zhang, Qing Yu, Zhijian Li, Yongchao Zhao, Yi Sun
Protein neddylation and its role in health and diseases. Signal transduction and targeted therapy 9 (1) (2024)
Lemin Li, Linchen Wang, Dian Liu, Yongchao Zhao
BRD7 suppresses tumor chemosensitivity to CHK1 inhibitors by inhibiting USP1-mediated deubiquitination of CHK1. Cell death discovery 9 (1) (2023)
Xue Liang, Jiping Yao, Danrui Cui, Weiyang Zheng, Yanning Liu, Guohua Lou, Bingjue Ye, Liyan Shui, Yi Sun, Yongchao Zhao, Min Zheng
The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway. Cell death and differentiation (2023)
Xue Liang, Jiping Yao, Danrui Cui, Weiyang Zheng, Yanning Liu, Guohua Lou, Bingjue Ye, Liyan Shui, Yi Sun, Yongchao Zhao, Min Zheng
The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway. Cell death and differentiation (2023)
Xue Liang, Jiping Yao, Danrui Cui, Weiyang Zheng, Yanning Liu, Guohua Lou, Bingjue Ye, Liyan Shui, Yi Sun, Yongchao Zhao, Min Zheng
The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway. Cell death and differentiation (2023)
Xue Liang, Jiping Yao, Danrui Cui, Weiyang Zheng, Yanning Liu, Guohua Lou, Bingjue Ye, Liyan Shui, Yi Sun, Yongchao Zhao, Min Zheng
The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway. Cell death and differentiation (2023)
Jian Chen, Zequn Li, Xing Jia, Wenfeng Song, Hao Wu, Hai Zhu, Zefeng Xuan, Yehui Du, Xingxin Zhu, Guangyuan Song, Haijiang Dong, Suchen Bian, Shuo Wang, Yongchao Zhao, Haiyang Xie, Shushen Zhen, Penghong Song
Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity. Oncogene 41 (22) (2022)
Yue Wang, Xiao Shen, Longyuan Gong, Yongchao Zhao, Xiufang Xiong
Functional characterization of FBXL7 as a novel player in human cancers. Cell death discovery 8 (1) (2022)
Xingxin Zhu, Guangyuan Song, Shiyu Zhang, Jun Chen, Xiaoyi Hu, Hai Zhu, Xing Jia, Zequn Li, Wenfeng Song, Jian Chen, Cheng Jin, Mengqiao Zhou, Yongchao Zhao, Hai-Yang Xie, Shushen Zhen, Penghong Song
Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in Liver Cancer via Inhibition of STAT3. Cancer research 82 (21) (2022)
Longyuan Gong, Danrui Cui, Dian Liu, Xiao Shen, Hui Pan, Xiufang Xiong, Yongchao Zhao
FBXW7 inactivation induces cellular senescence via accumulation of p53. Cell death & disease 13 (9) (2022)
Ying Ma, Danrui Cui, Linchen Wang, Yue Wang, Fei Yang, Hui Pan, Longyuan Gong, Minrun Zhang, Xiufang Xiong, Yongchao Zhao
P90 ribosomal S6 kinase confers cancer cell survival by mediating checkpoint kinase 1 degradation in response to glucose stress. Cancer science (2021)
Yanli Bi, Longyuan Gong, Pengyuan Liu, Xiufang Xiong, Yongchao Zhao
Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells. Cell death & disease 12 (4) (2021)
Yanli Bi, Danrui Cui, Xiufang Xiong, Yongchao Zhao
The characteristics and roles of β-TrCP1/2 in carcinogenesis. The FEBS journal 288 (11) (2020)